Womens Health, Wellness, and Reproductive Medicine

Welcome Message

Dear Speakers, Delegates, Exhibitors & Sponsors,

On behalf of the Organizing Committee, it is our distinct pleasure to welcome you to the "9^th Annual Congress on Women’s Health, Wellness, and Reproductive Medicine", taking place in Paris, France on December 08–09, 2025.

This international congress serves as a dynamic forum for healthcare professionals, researchers, policy advocates, and educators dedicated to advancing women's health. The event offers a unique opportunity to explore the latest research, clinical practices, and emerging innovations across women’s health, reproductive medicine, and overall wellness.

Over the course of two days, participants will benefit from keynote presentations, interactive sessions, and panel discussions led by internationally renowned experts. These sessions will highlight pressing challenges, pioneering solutions, and collaborative strategies aimed at improving healthcare outcomes for women globally.

We are confident that your participation will contribute to a stimulating exchange of knowledge and inspire meaningful collaborations. We look forward to welcoming you to Paris this December and to an engaging and impactful experience at Women’s Health 2025.

For any queries regarding the conference, please contact Ms. Lila prescott, Program Coordinator.

With warm regards,
Organizing Committee
Euros Womens Health 2025

About Conference

Euro Women's Health 2025 is delighted to invite experts from around the world in Obstetrics, Gynecology, Reproductive Medicine, and all areas of women's health to attend the "9th Annual Congress on Women's Health, Wellness & Reproductive Medicine," scheduled for December 08-09, 2025 in Paris, France. This event will serve as a global platform for specialists to share knowledge, explore the latest advancements, and collaborate on improving women's health outcomes. We look forward to welcoming you to this prestigious gathering in the heart of Paris.

Theme: "Innovating Women’s Health for a Healthier Future"

Euro Women's Health 2025 is a premier event dedicated to advancing discussions on the latest innovations, challenges, and strategies in women's health. The conference will cover a broad range of topics, including Reproductive Medicine, Gynecology, Gynecologic Oncology, Maternal and Fetal Health, Female Infertility, In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), Operative Gynecology, and more. This event will bring together esteemed Gynecologists, Fertility Specialists, Researchers, and Industry Experts from hospitals, academia, and various sectors to share insights through presentations, interactive case studies, workshops, symposiums, and networking opportunities.

In recognition of exceptional contributions in Gynecology, Obstetrics, Reproductive Medicine, and women's health, the Euro Women's Health 2025 Conference will feature the Young Researcher Forum (YRF), presenting the Young Research Award, along with honors for Best Poster and Best Presentation.

We invite all participants to join us in Milan for a transformative experience, where you can engage with leading professionals, expand your knowledge, and foster collaborations in the fields of Gynecology, Reproductive Medicine, and Women's Health.

Why Attend?

• Participate in a highly curated scientific program within a dynamic networking environment.
• Share ideas with thought leaders in Gynecology, Obstetrics, Midwifery, and Fertility.
• Connect with key decision-makers from hospitals and clinics globally.
• Stay informed on the latest trends and technologies in diagnosis and treatment.
• Engage in interactive debates and discussions based on evidence-based practices.
• Apply cutting-edge developments to your clinical work.
• Showcase your innovations on an international stage.

Sessions and Track

Track 01: Women’s health

Women's health has always been a significant concern, but today it has become a critical issue demanding heightened attention. While both men and women face similar health challenges, women's health requires special focus due to unique biological factors. For instance, processes such as pregnancy and childbirth pose significant health risks, particularly for young women aged 15 to 19 in developing countries, where they remain a leading cause of death. Additionally, HIV/AIDS is the leading cause of death among women of reproductive age, largely due to biological vulnerabilities and limited awareness of safe sex practices and HIV prevention. A lack of access to contraception further contributes to unwanted pregnancies, unsafe abortions, and the spread of sexually transmitted infections.

Track 02: Gynecology & Obstetrics

Gynecology is a branch of medicine dedicated to women's reproductive health, focusing on the diagnosis, treatment, and care of the female reproductive system, including the vagina, uterus, ovaries, and fallopian tubes. It also encompasses the screening and management of breast health issues. In addition, gynecologists may address problems related to the bowel, bladder, and urinary system, as these are closely connected to the reproductive organs. Gynecology forms the foundation of reproductive healthcare for most women throughout their lives. However, once a woman becomes pregnant, her care typically transitions to an obstetrician.Obstetrics specializes in the care of pregnant women, the unborn baby, labor, delivery, and the postpartum period. Obstetricians ensure that both mother and baby receive optimal prenatal care, aiming for a safe labor and delivery. If complications arise, they are trained to intervene promptly and effectively. Their role covers the entire process, from pregnancy through childbirth and the immediate postnatal phase, ensuring the well-being of both mother and child.

Track 03: Midwifery

Midwifery is a healthcare profession focused on pregnancy, childbirth, and the postpartum period. Midwives are trained health professionals who assist healthy women during labor, delivery, and after childbirth. They may attend births in various settings, including birthing centers, homes, or hospitals. Women who choose midwives typically prefer minimal medical intervention and have experienced low-risk, uncomplicated pregnancies. Midwifery care involves not only supporting women through the birthing process but also preventing health issues during pregnancy, identifying any abnormal conditions, seeking medical assistance when needed, and performing emergency procedures if medical help is unavailable.

Track 04: Reproductive and Sexual Health

Sexual health refers to a state of physical, mental, and social well-being in relation to sexuality. It involves a positive, respectful approach to sexual relationships and encompasses the ability to have safe and pleasurable sexual experiences, free from coercion, discrimination, and violence. Reproductive health focuses on the diseases, disorders, and conditions that affect the functioning of the male and female reproductive systems at all stages of life. Ensuring a healthy pregnancy is crucial for the well-being of women, infants, and families, and plays an essential role in preventing teen pregnancies. To maintain both reproductive and sexual health, individuals need access to accurate information and must be able to choose safe, effective, and acceptable contraception methods that suit their needs.

Track 05: Pregnancy

Pregnancy, or gestation, is the period during which one or more offspring develop inside a woman’s womb. In cases of multiple pregnancies, more than one offspring, such as twins, are carried. Pregnancy can result from sexual intercourse or through assisted reproductive technologies. Childbirth usually occurs around 40 weeks from the woman's last menstrual period (LMP), which is a little over nine months, with each month averaging 31 days. When calculated from fertilization, pregnancy lasts about 38 weeks. During the first eight weeks after fertilization, the developing offspring is referred to as an embryo, and after this period, it is called a fetus until birth. Early signs of pregnancy may include missed periods, tender breasts, nausea, vomiting, increased hunger, and frequent urination. Pregnancy can be confirmed with a pregnancy test.

Track 06: Infertility in women

Infertility is defined as the inability of a woman to conceive or to carry a pregnancy to full term. The use of infertility services is selective, with approximately 50% of women evaluated for infertility proceeding with treatment. Of those, only a small percentage receive advanced assisted reproductive technologies, such as in vitro fertilization (IVF). In reproductive health, obesity is particularly relevant to two key issues: infertility and heavy menstrual bleeding. Fertile women naturally experience a period of fertility around ovulation and are typically infertile during the latter part of the menstrual cycle. The management of heavy menstrual bleeding, especially in obese women, involves both medical and surgical interventions, including the challenges of performing hysterectomies in this population.

Track 07: Reproductive Medicine

Reproductive Medicine focuses on the prevention, diagnosis, and management of reproductive health issues. Its primary goals are to improve or maintain reproductive health and empower individuals to have children when they choose, as highlighted in numerous gynecologic studies globally. This field emphasizes a thorough understanding of reproductive anatomy, physiology, and endocrinology, while also integrating relevant aspects of molecular biology, biochemistry, and pathology. Additionally, it emphasizes the processes of replacing, engineering, or regenerating human cells, tissues, or organs to restore or establish normal function.

Track 08: Health Disorders & Obesity

Obesity is associated with a range of health disorders that can significantly impact an individual's overall well-being. It is linked to chronic conditions such as heart disease, diabetes, hypertension, and certain types of cancer. The excess body weight can lead to complications in various bodily systems, increasing the risk of metabolic syndrome, respiratory issues, and joint problems.Additionally, obesity can affect mental health, contributing to anxiety, depression, and low self-esteem. Addressing obesity requires a multifaceted approach that includes lifestyle changes, such as adopting a balanced diet and engaging in regular physical activity, along with medical interventions when necessary. Understanding the connection between obesity and health disorders is crucial for effective prevention and treatment strategies.

Track 09: Family Planning

A critical aspect of managing global population growth involves effective contraception and family planning measures. The world is experiencing significant advancements in contraceptive technologies and assisted reproductive technologies, including methods such as in vitro fertilization, artificial insemination, and surrogacy, which help address infertility and its assessment. High-risk patients, including those with conditions such as hypertension, sexually transmitted diseases, diabetes, and other complications, require special attention. The evolving trends in contraception and reproductive technologies play a vital role in influencing various reproductive health indicators.

• Family planning: Evaluating weight and blood pressure
• Advanced methods in family planning
• Teenage pregnancy
• Post-abortion family planning
• Age at menopause
• The distinction between contraceptives and family planning.

Track 10: Breastfeeding

Breastfeeding, also referred to as nursing, is the practice of feeding babies and young children with milk from a woman's breast. Breast milk is considered the ideal nourishment for infants, serving as their primary source of nutrition in the early stages of life. It offers numerous health benefits, including protection against gastroenteritis, diarrhea, ear and chest infections, allergies, and diabetes. Additionally, breastfeeding can reduce the risk of postpartum bleeding and provides essential immunity to the child. Moreover, it can aid in the mother’s weight management over time.

Track 11: Woman’s Oncology

Woman’s Oncology is a medical specialty focused on the prevention, diagnosis, and treatment of cancer. Professionals who specialize in this field are known as oncologists. Oncology encompasses various strategies aimed at combating cancer, including prevention, early detection, and effective treatment.

Three key components that have contributed to improved cancer survival rates are:

Prevention: Reducing risk factors, such as tobacco and alcohol use.

Early Diagnosis: Implementing screening programs for common cancers and conducting thorough diagnosis and staging.

Treatment: Employing advanced therapies tailored to individual patient needs.

Together, these elements play a crucial role in enhancing outcomes for cancer patients.

Track 12: Depression & Anxiety

Depression and anxiety are common mental health disorders that can significantly impact a person's daily life and overall well-being. Depression is characterized by persistent feelings of sadness, hopelessness, and a lack of interest or pleasure in activities. It can lead to physical symptoms such as fatigue, changes in appetite, and difficulty concentrating. Anxiety, on the other hand, involves excessive worry, fear, or apprehension about various situations or events. Individuals may experience symptoms such as restlessness, rapid heartbeat, and difficulty sleeping. Both conditions can occur simultaneously, compounding their effects and making management more challenging. Effective treatment options include therapy, medication, lifestyle changes, and support from friends and family. Understanding and addressing these mental health disorders is crucial for improving quality of life and promoting overall mental well-being.

Track 13: Breast and Ovarian Cancer

Breast cancer is a type of cancer that develops from breast tissue. Symptoms may include a lump in the breast, changes in breast shape, dimpling of the skin, fluid discharge from the nipple, a newly inverted nipple, or a red or scaly patch of skin. It is the most commonly diagnosed cancer among women worldwide, with nearly 1.8 million new cases reported in 2017, accounting for approximately 15% of all new cancer cases and 26% of all cancers diagnosed in women. In 2018, an estimated 266,000 new cases of invasive breast cancer were expected to be diagnosed in women in the U.S., along with about 64,000 new cases of in situ breast cancer.Ovarian Cancer refers to any cancerous growth that originates in the ovaries, which are the female reproductive organs responsible for producing eggs. This type of cancer ranks fifth in cancer-related deaths among women, resulting in more fatalities than any other cancers of the female reproductive system. A woman's lifetime risk of developing ovarian cancer is approximately 1 in 80. Early detection and awareness of symptoms are crucial for improving outcomes and survival rates in both breast and ovarian cancers.

Track 14: Menstrual Cycle

Menstrual cycle is a natural and regular sequence of changes that takes place in the female reproductive system. Controlled by female hormones, this cycle culminates in a monthly bleeding event from the uterus. Regular menstrual periods from puberty to menopause are generally signs of a healthy functioning body.The cycle is calculated from the first day of one period to the first day of the next. On average, a menstrual cycle lasts around 28 days, but it can vary significantly, ranging from 21 to 35 days in adults and from 21 to 45 days in young teens. Understanding the menstrual cycle is essential for women, as it allows them to monitor their reproductive health and detect any irregularities that may necessitate medical attention.

Track 15: Menopause & Osteoporosis

Menopause is a natural biological process characterized by the permanent cessation of menstrual periods. The transition to menopause occurs in three phases:

Perimenopause: This initial phase marks the beginning of the transition, during which a woman's body starts to undergo hormonal changes.

Menopause: This phase is defined as having experienced 12 consecutive months without a menstrual period.

Postmenopause: This phase generally occurs 24 to 36 months after the last period, during which symptoms often begin to subside.Menopause typically occurs between the ages of 49 and 52. Medical professionals confirm menopause when a woman has not experienced any vaginal bleeding for a year, which is often accompanied by a decrease in hormone production from the ovaries.One common concern associated with menopause is osteoporosis, a condition that leads to weakened bones and an increased risk of fractures. Osteoporosis results from a loss of bone mass and strength, leading to porous bones. While the exact cause of osteoporosis is not fully understood, it is particularly prevalent in postmenopausal women and occurs more frequently in women than in men.

There are two primary types of osteoporosis:

• Type I Osteoporosis: Also known as postmenopausal osteoporosis, this type occurs after menopause when estrogen levels drop significantly. It primarily affects trabecular bones within the hard cortical bone.
• Type II Osteoporosis: Known as senile osteoporosis, this type typically affects individuals around the age of 70 and results in the thinning of both trabecular and cortical bones.

Track 16: Abortion and Women health

Abortion is the procedure of removing an embryo or fetus from the uterus. There are two main types of abortion:

• Induced Abortion: This refers to a deliberate termination of a pregnancy. Induced abortions can have negative effects on a woman’s health, potentially leading to issues such as decreased fertility, increased susceptibility to sexually transmitted diseases, a higher risk of breast cancer, and mental health challenges. Unsafe abortions can result in severe complications or even death.
• Spontaneous Abortion: More commonly known as miscarriage, this occurs when an embryo or fetus is unintentionally expelled from the uterus before the 24th week of gestation. If a pregnancy ends before 37 weeks and results in a live-born infant, it is classified as a "premature birth" or "preterm birth." When a fetus dies in utero after the point of viability or during delivery, it is typically referred to as "stillborn." While the terms can sometimes overlap, premature births and stillbirths are generally not categorized as miscarriages.

Track 17: Sexually Transmitted Infection

An STI is an infection that is transmitted from one person to another through sexual contact. It occurs when bacteria, viruses, or parasites enter and multiply in or on the body. STIs are also referred to as sexually transmitted diseases (STDs). Some STIs can be cured with appropriate treatment, while others cannot.

Common Types of STIs Include:

• Human papillomavirus (HPV) infection
• Genital herpes
• Chlamydia
• Gonorrhea
• HIV and AIDS
• Syphilis

STIs are primarily spread through vaginal, oral, or anal sex. In the United States, over 9 million women are diagnosed with an STI each year. Women often experience more severe health complications from STIs compared to men, which can include infertility and other serious reproductive health issues. Awareness, prevention, and regular screenings are essential for managing STIs and protecting reproductive health.

Track 18: Labor and Birth

In the female reproductive system, labor represents the final phase of pregnancy. Childbirth is the process of delivering a baby along with the placenta, membranes, and umbilical cord from the uterus through the vagina to the outside world.

Labor is divided into three main stages:

• First Stage (Dilation): This stage begins with the onset of labor and is characterized by the cervix dilating to a diameter of about 10 cm (2 inches). It consists of two phases:
• Latent Phase: The early part of the first stage where contractions are mild and infrequent.
• Active Phase: The later part of the first stage when contractions become stronger and more regular, leading to further dilation of the cervix.
• Second Stage (Fetal Expulsion): This stage involves the actual delivery of the baby as the mother pushes during contractions.
• Third Stage (Placenta Delivery): In this stage, the placenta, along with any remaining membranes and the umbilical cord, is expelled from the uterus.
• Fourth Stage: This phase involves the immediate postpartum recovery period where the mother’s body begins to adjust after childbirth, monitoring for any complications.
• Understanding these stages is essential for preparing for labor and delivery

Track 19: Autoimmune Diseases

Autoimmune disease is a condition in which the immune system mistakenly attacks the body's own tissues. This condition is increasingly prevalent, yet researchers are still puzzled as to why it predominantly affects women.

Examples of Autoimmune Diseases Include:

• Rheumatoid arthritis
• Systemic lupus erythematosus
• Inflammatory bowel disease (IBD)
• Multiple sclerosis (MS)

Type 1 diabetes mellitus

• Guillain-Barre syndrome
• Chronic inflammatory demyelinating polyneuropathy
• Psoriasis, among others
• The early symptoms of many autoimmune diseases can be quite similar and may include:
• Fatigue
• Achy muscles
• Swelling and redness
• Low-grade fever
• Difficulty concentrating
• Numbness and tingling in the hands and feet
• Hair loss
• Skin rashes, among others
• Recognizing these early signs is crucial for timely diagnosis and management of autoimmune conditions.

Track 20: Infectious Diseases & Preventions

Infectious diseases are caused by pathogens, which include viruses, bacteria, fungi, and protozoa. While advancements in medicine have positively impacted women's health, infectious diseases remain a significant threat, claiming over 15 million lives worldwide each year.

Preventing the Spread of Infectious Diseases

To reduce the risk of transmission, consider the following preventive measures:

• Wash your hands frequently.
• Get vaccinated to protect against preventable diseases.
• Use antibiotics responsibly to combat bacterial infections without contributing to resistance.
• Stay at home if you exhibit signs or symptoms of an infection.
• Practice safe food preparation to avoid foodborne illnesses.
• Disinfect high-touch areas in your home to reduce contamination.
• Engage in safer sex practices to minimize the risk of sexually transmitted infections.
• Avoid sharing personal items to prevent the spread of pathogens.
• Implementing these strategies can help protect you and others from infectious diseases.

Track 21: Unintended pregnancy

Unintended pregnancy is defined as a pregnancy that occurs either when a woman wishes to become pregnant in the future but not at the time she became pregnant, or when she does not wish to become pregnant at all, either then or at any time in the future. Unintended pregnancies are associated with various negative health outcomes for both mothers and children, regardless of the eventual outcome of the pregnancy. Efforts to reduce the rates of unintended pregnancies have concentrated on improving access to effective contraception, enhancing counseling, and eliminating barriers to contraception access.

In contrast, an intended pregnancy is one that is actively desired at the time of conception or even earlier. For research purposes, all pregnancies that are not explicitly classified as "unintended" are grouped together, including those in which the individual may feel ambivalent or uncertain about the pregnancy.

Track 22: Endometriosis

Endometriosis is a condition characterized by the growth of tissue similar to the inner lining of the uterus (endometrial tissue) outside the uterus. In medical terminology, these growths are often referred to as lesions, nodules, or implants. Most commonly, endometrial patches develop in the pelvic cavity, typically on or around the ovaries, behind the uterus, or on surrounding tissues, as well as on the bowel or bladder.The primary symptom of endometriosis is pelvic pain, which is often associated with the menstrual cycle. This pain may manifest as cramping that is more severe than typical menstrual discomfort. One of the major complications of endometriosis is infertility, with approximately 30-50% of women affected by the condition experiencing difficulties in conceiving.

Track 23: Urogynecology

Urogynecology is a surgical subspecialty that combines aspects of urology and gynecology. Urogynecologists are specially trained medical professionals who address clinical issues related to pelvic floor dysfunction and bladder problems. Common disorders treated in this field include urinary incontinence, pelvic organ prolapse, and fecal incontinence. Other conditions managed by urogynecologists encompass cystocele, enterocele, female genital prolapse, lichen sclerosus, overactive bladder, and rectovaginal fistula.In contemporary practice, urogynecologists also provide care for women who experience perineal trauma during childbirth. Key treatments offered in urogynecology include abdominal reconstruction, behavioral modifications, botulinum toxin injections, dietary adjustments, robotic reconstruction, sacral nerve stimulation, and urethral injections. These interventions are designed to address urinary incontinence and pelvic organ prolapse effectively.

Visa Application

The Organizing Committee of the 9^th Annual Congress on Women’s Health, Wellness, and Reproductive Medicine would like to clarify that we are not authorized to intervene in or facilitate visa application procedures for attendees. Participants who require a visa to travel to France are responsible for contacting their respective embassies or consulates and ensuring that all required documentation is submitted accurately and on time.

As part of your visa application process, you may be asked to provide several supporting documents, such as a Letter of Invitation, a Letter of Abstract Acceptance, and a Registration Payment Receipt.

Letter of Invitation

A Letter of Invitation will be issued upon acceptance of your abstract and confirmation of your registration. This letter is intended to support your visa application and will be issued in English, confirming your scheduled participation in the congress. Please note that an invitation letter does not guarantee visa approval.

Token Payment for Documentation

A token payment of USD 200 can be submitted in order to obtain a payment receipt, which may also be included with your visa application documents. This amount is considered a partial registration fee and will be deducted from your total registration upon full payment.

Important Notice

Should your visa application be denied, the Organizing Committee cannot influence the decision of the Ministry of Foreign Affairs or engage in correspondence with embassies or consulates on your behalf. If your visa is officially rejected and proof of denial is provided in writing, the paid registration fee will be eligible for a refund, subject to verification and processing.

We strongly encourage all international participants to initiate their visa process well in advance to avoid last-minute complications. For any assistance with documentation after registration, please contact us at contact@europeanmeets.com.

Participation categories

 Oral Presentation

Oral presentations provide a platform for professionals to share their research findings, theoretical models, clinical experiences, and personal narratives related to women's health, reproductive medicine, and wellness. These sessions aim to foster learning, dialogue, and innovation in practice. Presenters are encouraged to keep their talks concise and informative within a 30-minute slot—20–25 minutes for the main presentation followed by a brief Q&A moderated by the Session Chair. Keynote speakers will be allotted 40–45 minutes to deliver deeper insights into groundbreaking developments in the field.

Workshop Presentation

Workshops offer a more interactive and skill-building experience, allowing presenters to demonstrate clinical techniques, health education tools, or wellness practices in a hands-on format. These 45–50 minute sessions are ideal for sharing simulation-based learning, counseling methods, or community outreach strategies. Workshops may be presented solo or as a collaborative effort with colleagues, and team presenters are eligible for group registration waivers. This format is perfect for those looking to engage their audience with experiential content.

Poster Presentation

The Student Poster Competition is a key highlight of the congress, designed to promote early-career research in women’s health and wellness. Nursing students, medical trainees, and public health scholars are encouraged to submit original research or case studies. Selected presenters will display their posters in a physical format (1x1 meter) and deliver a 5–7 minute explanation to judges and attendees. This opportunity allows emerging professionals to gain visibility, exchange ideas, and receive constructive feedback on their work.

Webinar Presentation

For those who are unable to attend in person due to travel or scheduling limitations, we offer a virtual presentation option. Webinar presenters may submit a pre-recorded video of their session, which will be featured during a scheduled time for online participants. This format ensures that distance does not limit valuable contributions to the scientific program and allows presenters to reach a broader international audience.

E-Poster Presentation

E-Poster presentations provide a modern alternative to traditional poster displays. All approved E-Posters will be published on the official congress website for digital viewing, and the corresponding abstracts will be included in the printed souvenir and indexed journal. Each abstract will be assigned a DOI (Digital Object Identifier), enhancing academic visibility and enabling future citation. This is an ideal format for participants seeking increased reach and professional recognition.

Exhibition Opportunities

Organizations involved in healthcare, wellness, pharmaceuticals, diagnostics, reproductive health, or education are invited to exhibit at the congress. Exhibitors will have the opportunity to connect with a global audience of healthcare professionals, researchers, educators, and policymakers. Both commercial and non-commercial institutions are welcome, including hospitals, wellness brands, research institutes, and medical device companies. To learn more about booth packages and exhibitor benefits, please contact contact@europeanmeets.com.

Advertisement

The official conference program is distributed to all attendees and used throughout the event as a reference guide. Advertising in the program is a strategic opportunity for organizations looking to promote their services, products, or initiatives to a focused and influential audience. For advertisement options and pricing details, kindly send your proposals to contact@europeanmeets.com.

Sponsorship Opportunities

We invite institutions and companies to support the congress through our official sponsorship packages. Both Premium and Additional Sponsorship opportunities are available, offering valuable benefits such as brand promotion, speaking slots, logo placements, and exhibitor space. Sponsoring the event allows your organization to be recognized as a leader in advancing women’s health, wellness, and reproductive medicine. For more information, contact our Program Manager at contact@europeanmeets.com or via WhatsApp at +44 2045861247.

Abstract Submission Criteria & Eligibility

The Organizing Committee of the "9^th Annual Congress on Women’s Health, Wellness, and Reproductive Medicine" invites researchers, healthcare professionals, academicians, and advocates to submit abstracts for presentation at the congress. We welcome submissions related to all aspects of women's health, reproductive medicine, public health, maternal wellness, mental health, policy development, and innovation in care delivery.

Presentation Requirements

All presenting authors are expected to complete their registration and are responsible for their travel and accommodation expenses. Upon acceptance, presenters will receive an official Letter of Acceptance via email, which will enable them to proceed with their registration and visa application (if applicable). Accepted abstracts will be compiled and published in the official Conference Abstract Book, which will be made available to all participants at the event.

If the presenting author is unable to attend the congress in person, it is their responsibility to appoint a qualified co-author or colleague to present on their behalf. In such cases, the Organizing Committee must be informed in advance to make necessary updates in the conference program.

Submission Options

We offer the following presentation formats for abstract submission:

• Oral Presentations: Standard oral presentations will be organized into thematic sessions. Each presenter will be allocated 30 minutes, including time for audience interaction and Q&A.
• Keynote Presentations: Selected leaders and experts in women’s health and reproductive medicine will deliver keynote addresses in 45-minute slots, providing deep insights and forward-thinking perspectives.
• Workshops & Special Sessions: Workshops will focus on clinical practices, case-based learning, or skill development and will be allocated 60 minutes per session, including interactive components.
• Symposium Sessions: These sessions will offer a collaborative platform for in-depth discussion on a focused topic area. Each symposium will run for 60 minutes, followed by 5 minutes of Q&A to engage participants in meaningful dialogue.

Market Analysis

Global Gynecological Devices Market Overview

The global gynecological devices market is characterized by a high level of fragmentation due to the presence of numerous large manufacturers, as highlighted in a recent study by Transparency Market Research (TMR). This fragmentation offers significant opportunities for market consolidation in the near future. Leading companies such as Cooper Surgical, Boston Scientific Corporation, and Olympus Corporation stand out for their extensive product portfolios and broad geographical reach. These companies are focused on developing non-invasive devices to cater to a larger consumer base, which will facilitate their geographical expansion.

The growing demand for medical solutions addressing women-centric health issues presents considerable growth potential in the gynecological devices market. Smaller regional players play a vital role and hold a significant market share. However, increasing entry barriers and stringent regulations for product approval are limiting the entry of new companies. Additionally, inadequate funding from venture capitalists poses challenges for new market entrants. According to TMR projections, the global gynecological devices market is expected to achieve a CAGR of 4.8% between 2017 and 2023, translating to revenue growth from USD 17,015.9 million in 2017 to approximately USD 22,589.9 million by 2023. Gynecological surgical devices are particularly prominent in the market, driven by the rising prevalence of single incision laparoscopic surgeries and advancements in conventional endoscopic procedures. North America is recognized as a lucrative market for gynecological devices, attributed to the early adoption of advanced technologies.

Product Insights

The global gynecological devices market is segmented by product type into gynecological imaging devices, surgical devices, and hand instruments. In 2016, surgical devices held the largest market share, primarily due to the high usage of endoscopy devices and female contraceptives. The demand for durable and autoclavable surgical instruments has increased in response to the growing number of surgical procedures worldwide. Furthermore, advancements in technology and the introduction of highly efficient devices capable of delivering quick and accurate diagnoses while minimizing operating times are anticipated to drive market growth in the coming years.

Global Market for Women’s Health

The global market for women's health therapeutics is projected to grow from approximately USD 33.0 billion in 2015 to nearly USD 40.6 billion by 2024, reflecting a CAGR of 4.2% during this period. The market for infertility treatment devices is expected to rise from USD 1,822.32 million in 2015 to USD 3,698.92 million by 2020, achieving a CAGR of 15.21%. These devices are essential in assisted reproductive technologies (ART), including in vitro fertilization, intracytoplasmic sperm injection, and surrogacy, for addressing infertility issues.